Brokerage Firm Rating on TherapeuticsMD (TXMD)

TherapeuticsMD (TXMD) : 4 brokerage houses believe that TherapeuticsMD (TXMD) is a Strong Buy at current levels. Zacks Investment Research suggests a Sell with a rank of 4.The median of all the 4 Wall Street Analysts endorse the stock as a Strong Buy with a rating of 1.

TherapeuticsMD (TXMD) stock is expected to deviate a maximum of $2.5 from the average target price of $15.63 for the short term period. 4 Street Experts have initiated coverage on the stock with the most promising target being $18 and the most muted being $13.


For the current week, the company shares have a recommendation consensus of Buy. TherapeuticsMD (NYSEMKT:TXMD): The stock opened at $7.49 on Thursday but the bulls could not build on the opening and the stock topped out at $7.60 for the day. The stock traded down to $7.06 during the day, due to lack of any buying support eventually closed down at $7.22 with a loss of -3.60% for the day. The stock had closed at $7.49 on the previous day. The total traded volume was 1,989,868 shares.

In a related news, Collins Cooper C., director of Therapeuticsmd, Inc., had purchased 16,000 shares on March 11, 2016. The total value of the transaction was $99,680. The information was disclosed with the SEC in a Form 4 Filing. The information is based on open market trades at the market prices.Option exercises are not covered.

TherapeuticsMD, Inc. is a womens health care product company. The Company is engaged in creating and commercializing products for women. The Company is focused on conducting clinical trials necessary for regulatory approval and commercialization of advanced hormone therapy pharmaceutical products. It manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter (OTC) vitamins. It markets its prescription and OTC prenatal vitamins and other products under its vitaMedMD brand name and duplicate formulations of its prescription prenatal vitamin products, also referred to as generic formulations, under its BocaGreenMD brand name. The Companys products include prenatal vitamins, vitaMedMD Plus Rx, vitaMedMD One Rx, vitaMedMD RediChew Rx and BocaGreenMD Prena1 line of prescription prenatal vitamins, which included three prescription prenatal vitamins that were generic formulations of its vitaMedMD-branded prescription prenatal vitamins.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.